E-resources
Peer reviewed
-
Shrestha, Ramina Maharjan; Mahiya, Kuldeep; Shrestha, Asmita; Mohanty, Soumya Ranjan; Yadav, Sanjeev Kumar; Yadav, Paras Nath
Inorganic chemistry communications, March 2024, 2024-03-00, Volume: 161Journal Article
Display omitted •Coumarin Thiosemicarbazones: acidic hydrogen at N(1) involved in intramolecular hydrogen bonding with lactone carbonyl forming more stable E isomer than Z isomer.•Cu(II) complex: distorted square planar, carbonyl O, imine N, thiolate S−, and Cl− ion coordinated.•In Vitro: anticancer activity in dose dependent manner against MCF-7 and MDA-MB-231 cells.•In Silico: follows Lipinski’s rule and high binding energy (−5.8 to −8.0 Kcal/mol) against EGFR and HER-2. A series of 3-acetylcoumarin-based thiosemicarbazones and their copper(II) complexes were synthesized and characterized by elemental analysis, IR, UV–Vis, HR-ESI Mass, NMR, EPR and single crystal XRD. The XRD study revealed thione tautomer for TSCs 3 (AcCmDEtTSC) and 4 (AcCmDPrTSC) whereas Cu(II) complex 8Cu(AcCmDPrTSC)Cl has distorted square planar geometry around the metal ion. Compound 1 (AcCmMeHTSC) among the thiosemicarbazones (TSCs) was more effective against both breast cancer cell lines: MCF-7 (IC50; 13.02 µg/mL) and MDA-MB-231 (IC50; 42.71 µg/mL), whereas compounds 7Cu(AcCmDEtTSC)Cl (IC50; 32.84 µg/mL) and 8Cu(AcCmDPrTSC)Cl (IC50: 34.69 µg/mL) among the Cu(II) complexes were more effective against MDA-MB-231 cell lines. Anticancer activity of the test compounds enhanced in dose dose-dependent manner against both MCF-7 and MDA-MB-231 cells. Molecular docking study showed significant binding affinity of the test compounds, notably compound 2 (AcCmEtHTSC) with −7.1 kcal/mol and −8.0 kcal/mol, compound 3 with −7.3 kcal/mol and −7.8 kcal/mol against target proteins EGFR and HER2 respectively. Although the IC50 value of the synthesized compounds is not very encouraging, their significant binding affinity values (−5.8 kcal/mol to −8.0 kcal/mol) against the target proteins EGFR and HER 2 is encouraging for the further exploration of their anticancer activity in the future.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.